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doi:10.1016/j.ejvs.2008.08.025Abstract Objective: To evaluate reliability and validity of the Dutch translated Aberdeen
Varicose Vein Questionnaire (AVVQ) for measuring health related quality of life (HR-QOL) in
patients with venous disease in the lower limb.
Methods: The AVVQ consists of 13 questions related varicose veins. This study assessed feasi-
bility, reliability and validity of the Dutch translated AVVQ in a sample of 145 patients with
venous disease of the leg. Test and retest of the Dutch translated AVVQ were performed within
a 2 week interval.
Results: There was a high test (99%) and retest (97%) response. Feasibility; AVVQ showed few
missing answers (0.6%) and non-unique answers (0.2%). Regarding internal consistency; Cron-
bach’s a exceeded 0.7 indicating a high level of concordance between the AVVQ questions
(aZ 0.76). Testeretest reliability; Spearman’s rho showed a significant strong association
between test and retest scores (rhoZ 0.87). Discriminative validity; AVVQ score was able to
differentiate between subgroups of patients with different severity of venous disease accord-
ing to the CEAP classification (ManneWhitney U test, p< 0.01).
Conclusions: This study supports applications of the Dutch AVVQ in HR-QOL measurement in
patients with venous disease in the Netherlands and the Flemish speaking part of Belgium.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.ciscus Hospital Rotterdam,
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ty for Vascular Surgery. PublisheIntroduction
Venous disease in the lower limb accounts for substantial
healthcare expenditure in the western world.1,2 A disease
specific quality of life (QOL) measurement should be
included in the measurement of outcome to assess the
effect of treatment for varicose veins. The Aberdeend by Elsevier Ltd. All rights reserved.
Dutch Translated Aberdeen Varicose Vein Questionnaire 233Varicose Vein Questionnaire (AVVQ) was developed and
validated by Garratt for measuring QOL in patients with
varicose veins of the leg.3,4 There is no translation and
validation of the AVVQ in any other language. We adapted
the AVVQ into Dutch following international guidelines,
including three independent forward and two backward
translations. This is discussed in the Methods.
To implement the AVVQ in the Netherlands we assessed
feasibility, score distribution, reliability and known-group
validity of the Dutch AVVQ in a sample of patients with
venous disease of the lower limb.Methods
The Aberdeen Varicose Vein questionnaire
The questionnaire consists of 13 questions (items) related
to lower limb venous disease and is shown in Table 1.
Question 1 is a diagram, where patients draw the location
of their varicose veins. Questions 7 and 9 may only be
answered with yes or no. The other questions had multiple
response options. Questions 3 and 9 were answered with
frequency of pain and use of painkillers. Questions 1, 2, 5,
6, 7, 8 and 9 should be answered for both legs.
Item scores were summed up after recoding the scores,
which resulted in a scale score from zero to 100, with zero
representing the best score, and 100 the worst score.
Adaptation process
The process followed to adapt the AVVQ into Dutch was
based on Bullinger.5 In brief, three translators, all native
speakers in Dutch, independently translated the ques-
tions and the response options of the original English
AVVQ into Dutch. They were instructed to pay attention
to conceptual rather than literal equivalence, and to
choose words and language constructions that were as
simple as possible. The translators were vascular
surgeons. The three resulting independent forward
translations were compared and discussed in a group
meeting of the three translators. Differences were
documented and discussed until consensus was reachedTable 1 The Aberdeen Varicose Vein questionnaire
1 Please draw in your varicose veins in the diagram below (Fig. 1
2 In the last two weeks, for how many days did your varicose vei
3 During the last two weeks, on how many days did you take pai
4 In the last two weeks, how much ankle swelling have you had?
5 In the last two weeks, have you worn support stockings or tigh
6 In the last two weeks, have you had any itching in association
7 Do you have purple discolouration caused by tiny blood vessels
8 Do you have a rash or eczema in the area of your ankle?
9 Do you have a skin ulcer associated with your varicose veins?
10 Does the appearance of your varicose veins cause you concern
11 Does the appearance of your varicose veins influence your cho
12 During the last two weeks, have your varicose veins interfered
13 During the last two weeks, have your varicose veins interfered
and social life)?about the optimal phrasing of the Dutch AVVQ. This
common forward translation was then given to two
translators who were native speakers in English and fluent
in Dutch. They each produced a backward translation that
was both compared to the original AVVQ for conceptual
equivalence with the original source version. The analysis
was documented and necessary adaptations to the Dutch
AVVQ version were made. The resulting Dutch AVVQ was
then administrated to three patients with venous disease
of the lower limbs to provide qualitative testing of
readability and comprehension. Because this qualitative
testing revealed no problem with the Dutch AVVQ, it was
subsequently administrated in the study population to
collect data for psychometric analysis.
The complete Dutch translated AVVQ is provided in the
Appendix. It may be used without licence fee in scientific
projects.
Study population and data collection
All patients who visited our outpatient clinic in Rotterdam,
the Netherlands, with venous disease of the leg, were
asked to participate in this study. No patient refused to
participate. In total 145 patients were included in 18
months, with at least 20 patients in each C-group of the
[Clinical-Etiology-Anatomy-Pathophysiology] (CEAP classifi-
cation), ranging from C1 to C6 (Table 1).6
All patients received the AVVQ on the day of their
outpatient clinic visit (questionnaire 1).
Questionnaires were filled in at home and returned
directly by mail. A second copy of the AVVQ (questionnaire 2)
was sent to the participants by mail after two weeks and was
returned as well, to determine the testeretest reliability. If
patients had a delay in returning the questionnaires,
a reminder telephone call was made once. No patients were
treated for their venous disease of the leg between test and
retest.
Analysis
Only questionnaires with at least a 90% response to all
items were eligible for analysis. In case of non-unique
responses (more than one response per item), a random)
ns cause you pain or ache?
nkilling tablets for your varicose veins?
ts?
with your varicose veins?
in the skin, in association with your varicose veins?
?
ice of clothing including tights?
with your work/housework or other daily activities?
with your leisure activities (including sport, hobbies
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a missing item response the total possible score for that
item was subtracted from the maximum possible score
for the scale. By doing so, a sumscore could still be
calculated by dividing the total score by the new
maximum possible score and multiplying by 100. For the
items relating to left and right legs, some patients
suffering from varicose veins in only one leg had
a tendency to miss out boxes for the unaffected leg,
rather than ticking the first box implying no symptoms.
If a patient consistently missed out the response set for
one leg had not drawn in any varicose veins on that leg
in question 1 (Fig. 1), their missing responses were
coded zero (no symptoms).
Evaluation of feasibility consisted of the assessment of
response rates, and missing/non-unique answers. Score
distribution was assessed by floor (25% of respondents or
more exhibiting the worst possible score) and ceiling (25%
of respondents or more exhibiting the best possible
score) effects. Cronbach’s a was used to evaluate
internal consistency of the AVVQ.7 This test assesses the
average level of correlation between questions in
a questionnaire. If the questionnaire is measuring
a specific problem (venous disease of the leg), then there
should be a high level of concordance between these
questions. If a questionnaire is to be reliable, alpha
should exceed 0.7. Testeretest reliability of the AVVQ
scores was assessed by Spearman’s correlation coefficient
(rho), by two sided Wilcoxon’s signed rank tests, and by
effect size: dZ [mean(a)mean(b)]/SD at the first
measurement.8 Effect sizes can be interpreted as
follows: dZ 0.2e0.5 is considered a small effect size,
dZ 0.5e0.8 is considered a medium effect size and
d> 0.8 is a large effect size.
The discriminative ability between subgroups of
patients with different severity of venous disease was
assessed by ManneWhitney U tests, and effect sizes.8Figure 1 Diagram of legsResults
Response
Questionnaire 1 was returned by 143 patients (test response
99%). There were no incomplete forms. Questionnaire 2 was
returned by 140 patients (retest response 97%) with no
incomplete forms. The five patients who did not return
questionnaire 2 included the two patients who also did not
return questionnaire 1. The age range was 23e85 years (mean
54; SD 13); 69% was female. There were at least 20 patients in
every C-class of the CEAP classification (Table 1).
Feasibility
The AVVQ showed few missing answers (0.6% on average) and
non-unique answers (0.2% on average). Some spontaneous
remarks were made regarding the first item, in which patients
had todrawtheir varicoseveins inapictureofboth legs (Fig. 1)
(e.g. ‘there are only varicose veins on my ankle and foot’).
Score distributions and internal consistency
Two items of the AVVQ had floor effects. These were items
‘degreeof ankle swelling’ (28%) and ‘any discolouration?’ (45%).
None of the items had ceiling effects. Cronbach’s a was 0.76.
Testeretest reliability
Mean AVVQ test score was 19.16 (SD 12.09) and mean AVVQ
retest score was 19.62 (SD 11.76). Spearman’s rho showed
a significant strong association between test and retest
scores (rhoZ 0.87, p< 0.01). Non-parametric testing for
differences between the average AVVQ scores at test and
retest (two sided Wilcoxon’s signed ranks test) was not
significant (pZ 0.12). The effect size was very small (0.04).(question 1 of AVVQ).






All patients (nZ 143) 19.54 (11.77) 16.11 (12.02) <0.01
Subgroup A (nZ 50) 11.12 (5.43) 9.24 (6.56) Z0.01
Subgroup B (nZ 50) 18.65 (9.04) 14.96 (9.84) <0.01
Subgroup C (nZ 43) 30.36 (11.57) 25.43 (13.36) <0.01
Subgroup A: clinical severity classes 1 and 2.
Subgroup B: clinical severity classes 3 and 4.
Subgroup C: clinical severity classes 5 and 6.
a Two-sided Wilcoxon’s signed ranks test.
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The AVVQ score was able to differentiate between
subgroups of patients with different severity of venous
disease (ManneWhitney U test, p< 0.01); the effect sizes
were large (0.84 and 1.01) (Table 2).Discussion
This study established the feasibility, reliability and validity
of the AVVQ in a Dutch population of outpatients with
varicose veins. The psychometric properties of the Dutch
AVVQ were similar to the original UK version. Score distri-
butions, internal consistency and testeretest reliability in
the Dutch sample have shown similar results as the UK
samples.3,4,9Appendix
Dutch translated AVVQ
1. Kunt u alstublieft uw spataderen in de pla
(te zien zijn een plaatje van uw benen van
achteren)
Benen gezien
van de voorzijdeIn the Dutch sample 2 items showed floor effects: ‘degree
of ankle swelling’ and ‘any discolouration?’. Regarding the
former item; many patients in the higher C-classification
suffered ankle swelling, which accounts for the floor effect
in this study. Regarding the latter item; the large proportion
of patients with small reticular veins may explain the high
number of patients endorsing this item. Cronbach’s a of 0.76
is comparable to internal consistency reported by Garrat
(Cronbach’s a of 0.72e0.74) in a UK sample.3,9
Conclusions
The current evaluation of the Dutch AVVQ showed proper-
ties that are largely comparable to those found in similar
UK samples. This supports applications of the Dutch AVVQ in
QOL measurement in patients with venous disease in the
Netherlands and the Dutch speaking part of Belgium.atjes hieronder tekenen:
 voren en uw benen van 
Benen gezien
van de achterzijde
4. In de laatste twee weken, hoeveel enkelzwelling heeft u gehad?
(vul één hokje in)                Geen enkele dag
Lichte enkelzwelling
Middelmatige enkelzwelling 
(U moest bijvoorbeeld uw benen
    hoog leggen wanneer mogelijk)
Ernstige enkelzwelling
(U had bijvoorbeeld problemen
           uw schoenen aan te trekken)
5. In de laatste twee weken, heeft u toen steunkousen gedragen?





Ja, steunkousen die ik zonder recept
gekocht heb
Ja, steunkousen van de dokter, 
die ik af en toe droeg
Ja, steunkousen van de dokter,
die ik iedere dag droeg
6. In de laatste twee weken, heeft u toen jeuk gehad door uw spataderen?





Ja, maar alleen boven de knie
Ja, maar alleen onder de knie
Boven én onder de knie
7. Heeft u paarse huidverkleuringen veroorzaakt door zeer fijne 
bloedvaatjes in de huid, in de buurt van uw spataderen?






2. In de laatste twee weken, gedurende hoeveel dagen had u pijnklachten 
van uw spataderen?





Tussen de 1 en 5 dagen
Tussen de 6 en 10 dagen
Gedurende meer dan 10 dagen
3. Gedurende de laatste twee weken, op hoeveel dagen gebruikte u 
pijnstillers voor uw spataderen?
(vul één hokje in) Geen enkele dag
Tussen de 1 en 5 dagen
Tussen de 6 en 10 dagen
Gedurende meer dan 10 dagen
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9. Heeft u een open been in verband met uw spataderen?






10. Verontrust het uiterlijk van uw spataderen u?
(vul één hokje in)            Nee
Ja, een beetje
Ja, heel erg 
11. Verontrust het uiterlijk van uw spataderen u dermate dat het uw
kledingkeuze bepaalt of dat u daarom steunkousen draagt?




12. Gedurende de laatste twee weken, hebben uw spataderen problemen 
gegeven bij uw werk/huishoudelijk werk of andere dagelijkse
activiteiten?
(vul één hokje in)            Nee
Ik was in staat te werken, maar mijn werk
heeft er licht onder moeten lijden
Ik was in staat om te werken, maar mijn werk
heeft er behoorlijk onder geleden
Mijn spataderen hebben me één of meer dagen 
verhinderd te werken
13. Gedurende de laatste twee weken, hebben uw spataderen problemen 
gegeven bij uw vrijetijdsbezigheden (zoals sport, hobby’s en uw sociale 
leven)?
(vul één hokje in)            Nee
Ja, het plezier was
licht verminderd
Ja, het plezier was
behoorlijk verminderd
Ja, mijn spataderen hebben me verhinderd
deel te nemen aan elke vrijetijdsbesteding
8. Heeft u huiduitslag of eczeem in de buurt van uw enkel?





Ja, maar het behoeft geen behandeling
van een dokter of verpleegkundige
Ja, en het moet worden behandeld
door de dokter of verpleegkundige
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